Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

Despite the challenges, many individuals with schizophrenia can lead fulfilling lives with the right treatment and support.

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Half Year Results Newron presents H1 2024 results and provides business update 19.09.2024 / 07:00 CET/CEST The issuer is solely responsible ...

About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective ...

The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.